Changing the Story for 8 Canadian Women Every Day
Ovarian and endometrial cancers take 8 Canadian women away from us every day. Detecting these cancers is often done so in late stages making survival rates low as 36%, due to vague symptoms and a lack of development in testing.
DOvEEgene, a Canadian team of doctors and researchers from the McGill University Health Center, are developing a new screening test for Ovarian Cancer to detect the disease early on leading to survival rates above 90%.
A Donation With Every Order
MPB has partnered with the DOVEEGENE team to help raise awareness about these diseases and raise funds for the project. With every order we donate to the cause.
DOVEEGENE is currently in the final stages of its clinical trials and looking for women aged 45 to 75 to participate. Once they gather enough samples, with the appropriate data, this test becomes available to all Canadian women from coast to coast.
